CLINICAL_TRIALS trial_result · 2021-11-03

Clinical Trial Update: Additional MDMA-assisted Therapy for People Who Relapsed After MDMA-assisted Therapy Trial [Phase 2]

Phase 2 study update exploring additional MDMA-assisted therapy for individuals who relapsed after prior MDMA-assisted therapy in PTSD.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Resilient Pharmaceuticals | Conditions: Posttraumatic Stress Disorder | Phase 2 | Status: COMPLETED | Results posted: 2021-11-03